How mRNA technology could upend the drug industry

January 11, 2021 | Posted in School of Medicine

Kira and its complement-target inhibitors plot run to the clinic with new investor cash just months after uncloaking

January 8, 2021 | Posted in School of Medicine

Looking to solve the solid tumor puzzle box, Carisma aims to take ‘CAR-M’ groundbreaker into early-stage trial

January 7, 2021 | Posted in School of Medicine, Startups

Passage Bio receives FDA clearance of IND application for lead gene therapy candidate PBGM01 for treatment of infantile GM1 Gangliosidosis

January 6, 2021 | Posted in School of Medicine, Startups

Hemogenyx Pharmaceuticals announces CAR-T agreement with Penn

January 6, 2021 | Posted in School of Medicine

EpiVario signs option agreement with Penn for a new epigenetic marker for Alzheimer’s Disease

January 6, 2021 | Posted in School of Medicine, Startups

Penn mRNA biology pioneers receive COVID-19 vaccine enabled by their foundational research

January 6, 2021 | Posted in School of Medicine

Equalize 2021

January 6, 2021 | Posted in Resources, Video

Gyroscope Therapeutics partners with a Penn gene therapy leader, Dr. Jean Bennett

January 2, 2021 | Posted in School of Medicine, Success Story

Gyroscope entered into a two-year sponsored research agreement with the Penn Center for Advanced Retinal and Ocular Therapeutics.

How Temple, Drexel and Penn predict which technologies will pilot the future

December 23, 2020 | Posted in Success Story

Filter

Success Stories

Highlights of the PCI news focused on Penn commercialization accomplishments

All Success Stories